Clinical efficacy of insulin-like growth factor-1 in a patient with autoantibodies to insulin receptors: A case report

Diabetes Research and Clinical Practice

Volumn 49, Issue 1, 2000, Pages 65-69

  Yamamoto, Tsunehiko ^a   Sato, Toshihiko ^a   Mori, Tomoko ^a   Yamakita, Tetsuya ^a   Hasegawa, Takanori ^a   Miyamoto, Masafumi ^a   Hosoi, Masayuki ^a   Ishii, Tomofusa ^a   Yoshioka, Katsunobu ^a   Tanaka, Shiro ^a   Fujii, Satoru ^a  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Anti insulin receptor antibodies; Insulin like growth factor 1; Insulin like growth factor 1 allergy; Type B insulin resistance syndrome

Indexed keywords

AUTOANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HEMOGLOBIN A1C; INSULIN RECEPTOR; INSULIN RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; RECOMBINANT SOMATOMEDIN C;

AGED; ANAPHYLAXIS; ARTICLE; CASE REPORT; DESENSITIZATION; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN RESISTANCE; MALE; PLASMAPHERESIS;

AGED; AUTOANTIBODIES; BLOOD GLUCOSE; C-PEPTIDE; CYCLOPHOSPHAMIDE; CYCLOSPORINE; DESENSITIZATION, IMMUNOLOGIC; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE AGENTS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MALE; PLASMA EXCHANGE; PLASMAPHERESIS; RECEPTOR, INSULIN; SYNCOPE;

EID: 0034052342     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(00)00129-7     Document Type: Article

References (28)

1. Kahn C.R., Flier J.S., Bar R.S. et al. The syndromes of insulin resistance and acanthosis nigricans. New Engl. J. Med. 294:1976;739-745.
2. Taylor S.I., Grunberger G., Marcus-Samuels B. et al. Hypoglycemia associated with antibodies to the insulin receptor. New Engl. J. Med. 307:1982;1422-1426.
3. Kobayashi M. Anti-insulin receptor antibody and insulin resistance. Nippon Naibunpitsu Gakkai Zasshi. 68:1992;11-18.
4. Flier J.S., Bar R.S., Kahn C.R. et al. The envolving clinical course of patients with insulin receptor antibodies: spontaneous remission or receptor proliferation with hypoglycemia. J. Clin. Endocrinol. Metab. 47:1978;985-995.
5. Sims R.E., Rushford F.E., Huston D.P., Cunningham G.R. Successful immunosuppressive therapy in a patient with autoantibodies to insulin receptors and immune complex glomerulonephritis. South Med. J. 80(7):1987;903-906.
6. Lalej-Bennis D., Selam J.L., Fluteau-Nadler S. et al. Extreme insulin resistance: clinical management by external subcutaneous insulin infusion. Diab. Metab. 23(6):1997;533-536.
7. Ponzio G., Dolais-Kitabgi J., Louvard D., Gautier N., Rossi B. Insulin and rabbit anti-insulin receptor antibodies stimulate additively the intrinsic receptor kinase activity. EMBO J. 6:1987;333-340.
8. Hagino H., Shii K. Enzyme-linked immunosorbent assay method for human autophosphorylated insulin receptor: applicability to insulin resistant states. Diabetes. 43:1994;274-280.
9. Salvatore D., Riccardo G. Insulin resistance and hypoglycemia in patients with systemic lupus erythematosus: description of antiinsulin receptor antibodies that enhance insulin binding and inhibit insulin action. J. Clin. Endocrinol. Metab. 73:1991;650-657.
10. Sharon S., Jer T., Marie P., Arnold S., Simeon T. Autoimmune thrombocytopenia and primary biliary cirrhosis with hypoglycemia and insulin receptor autoantibodies. Ann. Intern. Med. 107:1987;86-688.
11. Rochet N., Blanche S., Carel J. et al. Hypoglycaemia induced by antibodies to insulin receptor following a bone marrow transplantation n an immunodeficient child. Diabetologia. 32:1989;167-172.
12. Braund W., Naylor B. Autoimmunity to insulin receptor and hypoglycemia in patient with Hodgkin's disease. Lancet. 31:1987;237-240.
13. Di Paolo S. Metformin ameliorates extreme insulin resistance in a patient with anti-insulin receptor antibodies: description of insulin receptor and postreceptor effects in vivo and in vitro. Acta Endocrinol. 126:1992;117-123.
14. Terry J., Shirish C., Marianne M., John I. Insulin resistance and hyperinsulinemia induce hyperandrogenism in a young type B insulin-resistance female. J. Clin. Endocrinol. Metab. 72:1991;1308-1311.
15. Henrik V., Marianne R., Soren U., Jorn M., Oluf P. Short- and long-term metabolic effects of recombinant human IGF-I treatment in patients with severe insulin resistance and diabetes mellitus. Eur. J. Endocrinol. 136:1997;475-482.
16. Schoenle E., Zenobi P., Torresani T. et al. Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance. Diabetologia. 34:1991;675-679.
17. Kuzuya H., Matsuura N., Imura H. et al. Trial of insulin-like growth factor I therapy for patients with extreme insulin resistance syndromes. Diabetes. 42:1993;696-705.
18. Hirano T., Adachi M. Insulin-like growth factor 1 therapy for type B insulin resistance. Ann. Intern. Med. 127:1997;245-246.
19. Kobayashi M., Takata Y., Sasaoka T., Shigeta Y. Characterization of anti-insulin receptor antibody action. Biologic activity and kinase activity. Best Approach to the Ideal Therapy of Diabetes Mellitus. 1987;195-198 Elsevier.
20. L.R. James, C.R. Kahn, G.C. Weir, Principles of insulin therapy, in: Joslin's Diabetes Mellitus, 13th ed., Lea and Febiger, Philadelphia, PA, pp. 481-483.
21. Guler H.P., Schmid C., Zapf J., Froesch E.R. Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc. Natl. Acad. Sci. USA. 86:1989;2868-2872.
22. Guler H.P., Zapf J., Froesch E.R. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. New Engl. J. Med. 317:1987;137-140.
23. Froesch E.R., Zapf J. Insulin-like growth factors and insulin: comparative aspects. Diabetologia. 28:1985;485-493.
24. Merimee T.J., Zapf J., Froesch E.R. Insulin-like growth factors: studies in diabetics with and without retinopathy. New Engl. J. Med. 309:1983;527-530.
25. Grant M., Russell B., Fitzgerald C., Merimee T.J. Insulin-like growth factors in vitreous: studies in control and diabetics subjects with neovascularization. Diabetes. 35:1986;416-420.
26. Dills D.G., Moss S.E., Klein R., Klein B.E.K. Association of elevated IGF-I levels with increased retinopathy in late-onset diabetes. Diabetes. 40:1991;1725-1730.
27. Serri O., Beauregard H., Brazeau P. et al. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes. J. Am. Med. Assoc. 7:1991;(264) 888-892.
28. Hammerman M.R., Miller S.B. Renal cellular biology of growth hormone and insulin-like growth factor I. Pediatr. Nephrol. 5:1991;505-508.